Drug & Medication Database

Dosage form: POWDER. Active ingredients: EMTRICITABINE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: EMTRICITABINE (50 kg/50kg). Category: BULK INGREDIENT.

11 DESCRIPTION DESCOVY (emtricitabine and tenofovir alafenamide) is a fixed dose combination tablet containing emtricitabine (FTC) and tenofovir alafenamide (TAF) for oral administration. FTC, a synthetic nucleoside analog of cytidine, is an HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI). TAF, an HIV NRTI, is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate.

Brands: Descovy

Dosage form: TABLET, FILM COATED. Active ingredients: EMTRICITABINE (200 mg/1); TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Fixed-dose combination tablet indicated for HIV-1 treatment in adults and pediatric patients, and for pre-exposure prophylaxis (PrEP) in at-risk individuals.

Brands: Emtricitabine And Tenofovir Disoproxil Fumarate

11 DESCRIPTION Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are a fixed-dose combination tablet containing FTC, rilpivirine hydrochloride, and TDF. Emtricitabine, USP (FTC) is a synthetic nucleoside analog of cytidine. Rilpivirine (RPV) is a non-nucleoside reverse transcriptase inhibitor. Tenofovir disoproxil fumarate (TDF) is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate.

Brands: Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate

11 DESCRIPTION ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) is a fixed-dose combination tablet containing emtricitabine (FTC), rilpivirine (RPV), and tenofovir alafenamide (TAF) for oral administration. FTC, a synthetic nucleoside analog of cytidine, is an HIV-1 nucleoside analog reverse transcriptase inhibitor (HIV-1 NRTI). RPV is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).

Brands: Odefsey

Dosage form: TABLET, FILM COATED. Active ingredients: EMTRICITABINE (200 mg/1); RILPIVIRINE HYDROCHLORIDE (25 mg/1); TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION COMPLERA is a fixed-dose combination tablet containing FTC, rilpivirine hydrochloride, and TDF. Emtricitabine (FTC) is a synthetic nucleoside analog of cytidine. Rilpivirine (RPV) is a non-nucleoside reverse transcriptase inhibitor. Tenofovir disoproxil fumarate (TDF) is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate. COMPLERA tablets are for oral administration.

Brands: Complera

11 DESCRIPTION Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are fixed-dose combination tablets containing FTC, rilpivirine hydrochloride, and TDF. Emtricitabine (FTC) is a synthetic nucleoside analog of cytidine. Rilpivirine (RPV) is a non-nucleoside reverse transcriptase inhibitor. Tenofovir disoproxil fumarate (TDF) is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate.

Brands: Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate

Manufactured by CIPLA LIMITED. Dosage form: TABLET. Active ingredients: EMTRICITABINE, TENOFOVIR ALAFENAMIDE (200MG/25MG). Application: ANDA211680.

Emtricitabine and tenofovir disoproxil fumarate tablets are fixed-dose combination tablets containing emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF). FTC is a synthetic nucleoside analog of cytidine. TDF is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5'-monophosphate. Both FTC and tenofovir exhibit inhibitory activity against HIV-1 reverse transcriptase.

Brands: Emtricitabine/tdf

Topical Analgesic

Brands: Arthcal Soothing Pain Relief Massage Gel

11 DESCRIPTION Enalapril maleate oral solution is the maleate salt of enalapril, the ethyl ester prodrug of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Enalapril maleate is chemically described as (S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline, (Z)-2-butenedioate salt (1:1).

Brands: Enalapril Maleate

ACE inhibitor indicated for hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction.

Brands: Enalapril Maleate

DESCRIPTION Enalapril maleate and hydrochlorothiazide combines an angiotensin converting enzyme inhibitor, enalapril maleate, and a diuretic, hydrochlorothiazide. Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin converting enzyme inhibitor, enalaprilat. Enalapril maleate is chemically described as ( S )-1-[ N -[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline, ( Z )-2-butenedioate salt (1:1).

Brands: Enalapril Maleate And Hydrochlorothiazide

11 DESCRIPTION Enalapril maleate oral solution is the maleate salt of enalapril, the ethyl ester prodrug of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Enalapril maleate is chemically described as (S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline, (Z)-2-butenedioate salt (1:1). Its empirical formula is C 20 H 28 N 2 O 5 •C 4 H 4 O 4 , and its structural formula is: Enalapril maleate is a off-white, crystalline powder with a molecular weight of 492.52.

Brands: Enalapril Maleate Oral Solution

DESCRIPTION Enalaprilat injection, USP is a sterile aqueous solution for intravenous administration. Enalaprilat is an angiotensin-converting enzyme inhibitor. It is chemically described as (S)-1-[N-(1-carboxy-3-phenylpropyl)-L-alanyl]-L-proline dihydrate. Its molecular formula is C 18 H 24 N 2 O 5 •2H 2 O and its structural formula is: Enalaprilat, USP is a white or almost white crystalline powder with a molecular weight of 384.43.

Brands: Enalaprilat

11 DESCRIPTION Enasidenib is an inhibitor of isocitrate dehydrogenase-2 (IDH2) enzyme. Enasidenib is available as the mesylate salt with the chemical name: 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate. Or 2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino-1,3,5-triazin-2-yl]amino]-, methanesulfonate (1:1).

Brands: Idhifa

Purpose: Acen Treatment

Brands: Acne Phage Serum

Dosage form: POWDER. Active ingredients: ENCLOMIPHENE CITRATE (35 kg/35kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

11 DESCRIPTION Encorafenib is a kinase inhibitor. The chemical name is methyl N -{(2 S )-1-[(4-{3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-(propan-2-yl)-1 H -pyrazol-4-yl}pyrimidin-2-yl)amino]propan-2-yl}carbamate. The molecular formula is C 22 H 27 ClFN 7 O 4 S and the molecular weight is 540 daltons. The chemical structure of encorafenib is shown below: Encorafenib is a white to almost white powder.

Brands: Braftovi

Use: Temporary relief of headache

Brands: Endometrium Argentum

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Endotoxin Terrain Drops 2143

Purpose Male Genital Desensitizer

Brands: Spartan Wipes

Purpose antiperspirant

Brands: Unlimited By Degree

Purpose antiperspirant

Brands: Unlimited By Degree

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Energy Regulation Combination 9308

Manufactured by BAXTER HLTHCARE. Dosage form: LIQUID. Route: INHALATION. Active ingredients: ENFLURANE (99.9% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA017087.

11 DESCRIPTION Enfortumab vedotin-ejfv is a Nectin-4 directed antibody-drug conjugate (ADC) comprised of a fully human anti-Nectin-4 IgG1 kappa monoclonal antibody (AGS-22C3) conjugated to the small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE) via a protease-cleavable maleimidocaproyl valine-citrulline (vc) linker (SGD-1006).

Brands: Padcev Ejfv